R. Michael Blaese: still blazing a path of his own.
作者信息
Jenks S
出版信息
J Natl Cancer Inst. 1998 Aug 19;90(16):1188-91. doi: 10.1093/jnci/90.16.1188.
PMID:9719076
Abstract
摘要
相似文献
1
R. Michael Blaese: still blazing a path of his own.R·迈克尔·布莱兹：仍在开拓属于自己的道路。
J Natl Cancer Inst. 1998 Aug 19;90(16):1188-91. doi: 10.1093/jnci/90.16.1188.
2
Gene therapy infants faring well.
J Natl Cancer Inst. 1998 Aug 19;90(16):1191. doi: 10.1093/jnci/90.16.1191.
3
4
Genetic therapy using bone marrow transplantation.使用骨髓移植的基因治疗。
Cancer Treat Res. 1995;76:271-80. doi: 10.1007/978-1-4615-2013-9_12.
5
EMA greenlights second gene therapy.欧洲药品管理局批准第二种基因疗法。
Nat Rev Drug Discov. 2016 May 3;15(5):299. doi: 10.1038/nrd.2016.93.
6
Gene therapy.
Sci Am. 1990 Nov;263(5):68-72, 81-4. doi: 10.1038/scientificamerican1190-68.
7
Profile: gene doctor. W. French Anderson pioneers gene therapy.
Sci Am. 1990 Aug;263(2):33-33B. doi: 10.1038/scientificamerican0890-33.
8
At age 2, gene therapy enters a growth phase.在2岁时，基因治疗进入一个增长阶段。
Science. 1992 Oct 30;258(5083):744-6. doi: 10.1126/science.1472258.
9
A Journey in the Development of Gene Therapy for Inherited Disorders of the Bone Marrow.骨髓遗传性疾病基因治疗的发展历程
Hum Gene Ther Clin Dev. 2015 Dec;26(4):203-7. doi: 10.1089/humc.2015.29006.koh.
10
ADA2 deficiency: Clonal lymphoproliferation in a subset of patients.腺苷脱氨酶2缺乏症：部分患者中的克隆性淋巴细胞增殖
J Allergy Clin Immunol. 2018 Apr;141(4):1534-1537.e8. doi: 10.1016/j.jaci.2018.01.012. Epub 2018 Jan 31.
Zotero 插件